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ARTICLE
Inverting family GH156 sialidases define an unusual
catalytic motif for glycosidase action
Pedro Bule 1, Léa Chuzel2, Elena Blagova1, Liang Wu 1, Melissa A. Gray3, Bernard Henrissat4,
Erdmann Rapp 5,6, Carolyn R. Bertozzi3,7, Christopher H. Taron2* & Gideon J. Davies 1*
Sialic acids are a family of related sugars that play essential roles in many biological events
intimately linked to cellular recognition in both health and disease. Sialidases are therefore
orchestrators of cellular biology and important therapeutic targets for viral infection. Here, we
sought to define if uncharacterized sialidases would provide distinct paradigms in sialic acid
biochemistry. We show that a recently discovered sialidase family, whose first member
EnvSia156 was isolated from hot spring metagenomes, defines an unusual structural fold and
active centre constellation, not previously described in sialidases. Consistent with an
inverting mechanism, EnvSia156 reveals a His/Asp active center in which the His acts as a
Brønsted acid and Asp as a Brønsted base in a single-displacement mechanism. A pre-
dominantly hydrophobic aglycone site facilitates accommodation of a variety of 2-linked
sialosides; a versatility that offers the potential for glycan hydrolysis across a range of
biological and technological platforms.
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ialic acids are a family of unusual keto-sugars (2-keto-3-
deoxy-nononic acids) that have myriad roles in biology. The
C5-amino version is the most well-known neuraminic acid,
which is typically acetylated (Neu5Ac) or glycolated (Neu5Gc).
They are most typically found capping glycan-chains on both
glycoproteins and lipids and by virtue of their terminal positions
they are keenly positioned to play major roles in
protein–carbohydrate interactions and cellular recognition.
Additional modification of the sialic acid core expands the sialic
acid family, leading to sialic acids that can modulate or evade
biological recognition1,2.
In mammalian cells, sialosides (typically α2-3, -6 or -8 linked)
are perhaps most notable as a glyco-signature of cell type and
health; interacting with sialic-acid-binding lectins termed Siglecs
in diverse immune responses3–6. Sialic acids are also known as the
recognition point that facilitates host cell invasion by numerous
pathogenic viruses, such as influenza, certain parasites like Try-
panosoma cruzi, and harmful bacteria, such as Hemophilus
influenzae, Streptococcus pneumoniae, and Pseudomonas aerugi-
nosa7–15. There is, therefore, considerable interest in the proteins
that recognize sialic acids (both in the host and pathogens), and
the enzymes that cleave and release sialic acids (sialidases and
neuraminidases).
Sialidases have recently become of additional interest because
of their application in precision glycocalyx editing, with appli-
cations in cancer immunotherapy16. Cell surface sialosides are
harnessed by tumor cells to evade destruction by the immune
system. Sialidases, chemically linked to anti-cancer antibodies,
such as Trastuzumab, shave sialosides from the cancer cell surface
preventing binding by immune-suppressing Siglecs. Targeting
immune-modulating sialic acid enzymatically has thus gained
new importance and has spurred efforts to discover new
sialidases.
Sialidases, neuraminidases (EC 3.2.1.18) are glycoside hydro-
lases that cleave sialosides, typically acting in an “exo”-fashion at
the sialic acid cap of glycan chains. At the sequence level, these
enzymes have been classified into five of the CAZy sequence-
based families17; 33, 34, 58, 83, and the recent GH156 family,
described here. At the structural/mechanistic level, CAZy GH33,
34, and 83 are exo-sialidases, all displaying a similar six-fold β-
propeller motif and all performing catalysis with net retention of
anomeric configuration through the formation, and subsequent
breakdown, of a covalent intermediate to a conserved active
center tyrosine; elegantly revealed by the work of Newstead and
colleagues18. These enzyme families are perhaps the best known
and characterized, not least because they contain the influenza
virus sialidases (CAZy GH34), which are the target for the anti-
influenza drugs oseltamivir and zanamivir (Tamiflu and Relenza).
CAZy family GH58 is an unusual endo-polysialidase family (EC
3.2.1.129), also displaying a six-fold β-propeller motif but which,
in contrast to families 33, 34, and 83, acts with inversion of
anomeric configuration. It cleaves within poly (α-2,8) sialic acid
(PSA) polysaccharides mainly found in the capsule of some
bacterial pathogens, like Pasteurella haemolytica, Neisseria
meningitidis, and Escherichia coli, conferring them the ability to
evade the host’s immune system19–21, and in the mammalian
brain, where they are involved in several neurological processes
including neural plasticity, neural–cell interaction, and
growth22–24. Recently, the new CAZy family GH143 was created
to classify a B. thetaiotaomicron enzyme capable of cleaving 2-
keto-3-deoxy-D-lyxo-heptulosaric acid (Dha), a seven-carbon
sialic acid analog, from rhamnogalactorunan-II (RGII)25. It is a
bi-modular enzyme and it actually possesses two active centers
with distinct activities: one β-L-arabinofuranosidase (EC
3.2.1.185) site that releases L-arabinofuranose from RGII chain D
and a Dha-hydrolase site that subsequently cleaves chain D Dha
from the main galacturonic acid chain. The Dhase site presents a
slightly different fold from what is observed in other sialidases,
with a five-fold β-propeller, but it retains the typical
tyrosine–glutamate nucleophilic pair, implying it functions with a
similar retaining catalytic mechanism.
Recently, as part of an effort to discover novel sialidases with
potential biotechnological application, a family of exo-sialidases
has been defined through isolation of sialidase activities from a
freshwater hot spring environmental niche26. This family, termed
CAZy family GH156, is unusual in that its members act with
inversion of the anomeric configuration of the released sialic acid
suggesting they have a distinct active-center geometry (implying a
different 3-D topology for sialidase action). This enzyme was
shown to act on a variety of (typically α2-3, α2-6 linked) sialic
acid glycosides including complex N-glycans and O-glycan-linked
sialic acids, in solution26. Here we describe the 3-D structure and
catalytic center of the defining member, EnvSia156, of this siali-
dase family. We show, through ligand complexes with products
and sialidase inhibitors, that the 3-D structure and active center
are indeed an unusual arrangement, with family-conserved his-
tidine and aspartate residues defining the catalytic mechanism
that acts with inversion of anomeric configuration; facets not
previously observed in the canon of literature for sialidases.
Results and discussion
Expression, activity, and oligomeric status of EnvSia156. Gene
cloning, expression, and purification of recombinant EnvSia156
was performed as previously described by Chuzel et al. 26. The
kinetics of the purified recombinant protein used for crystal-
lization were determined, using the substrate depletion method27,
with 2′-(4-methylumbelliferyl)-α-D-N-acetylneuraminic (4MU-α-
Neu5Ac) as a substrate, at pHs between 3 and 8 (Fig. 1a). The
enzyme shows instability below pH 4.5, but the alkaline limb of
the pH profile may be fitted with a single ionization to give an
approximate optimal pH of 5 with a pKa of 6.8 for the descending
curve. At pH 5, the enzyme yielded a kcat of 4.28 ± 0.06 s−1 and
KM= 5.58 ± 0.05 µM (Fig. 1b) putting EnvSia156 amongst siali-
dases with the highest catalytic efficiency reported to date28,29. An
initial screen of potential inhibitors suggested that EnvSia156 was
inhibited by N-acetyl-2, 3-dehydro-2-deoxyneuraminic acid
(DANA) (Fig. 1c), but not by Siastatin B. An apparent inhibitor
constant (Ki) of 3.17 ± 0.41 µM was determined for DANA at low
substrate concentration ([S]≪ KM) using 4MU-α-Neu5Ac.
To ascertain the oligomeric status of EnvSia156, SEC-MALLS
experiments were performed, indicating that EnvSia156 was a
dimer in solution with an estimated absolute molecular mass
of 119.2 kDa. This closely approximated the predicted molecular
mass of an EnvSia156 dimer (117.4 kDa) calculated using the
ProtPram tool30 (Supplementary Fig. 1). The thermal stability
was assessed by differential scanning fluorimetry (DSF) at pH 5.5
and pH 7.5, and the obtained Tm values were 72 and 73 °C,
respectively (Fig. 1d). This is compatible with the average
reported temperature of 60 °C in the ecological niche from which
the enzyme originates. The slight increase in thermal stability at
pH 7.5 is in agreement with the pH stability curve.
The structure of EnvSia156 defines an unusual sialidase fold.
To explore the 3-D structure and molecular determinants
supporting the unique catalytic mechanism described by Chuzel
et al. 26, the structure of EnvSia156 was determined on its own
and in complex with N-acetylneuraminic acid (Neu5Ac), N-
glycolylneuraminic acid (Neu5Gc), 2-keto-3-deoxy-D-glycero-
D-galacto-nononic acid (KDN), and the inhibitor DANA. The
absence of related 3-D structures dictated the need for a sele-
nomethionine approach to phasing, so a selenomethionine
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derivative was crystallized and data collected at three different
wavelengths (selenium peak, inflection, and high-energy
remote). The resulting refined SeMet structure was subse-
quently used as the starting model for refinement of unliganded
EnvSia156 and complexes with 20 mM Neu5Ac, Neu5Gc,
DANA, KDN. Although all collected datasets were highly ani-
sotropic, which ultimately had a negative impact on refinement
statistics, they resulted in good quality 2Fo−Fc maps, with
clearly defined amino acid sidechains and ligands easily iden-
tifiable in the difference maps. The best model was obtained
from a crystal of EnvSia156 with bound Neu5Ac (EnvSia156-
Neu5Ac), at a resolution of 2.0 Å. Data collection and refine-
ment statistics for all structures are summarized in
Supplementary Table 1.
Two copies of the protein were present in the asymmetric
unit, each composed of two distinct domains (Fig. 2a, b). The
two copies appear to be related by non-crystallographic
symmetry resulting in a dimer, discussed below in light of the
interface analysis and SEC-MALLS results. The catalytic
domain (residues 6–376) comprises a complete (β/α)8-barrel
fold while the C-terminal domain (residues 377–502) consists
of an eight-stranded β-sandwich (Fig. 2d, e). The functional
side of a barrel enzyme is normally present on the “N-terminal”
face of the barrel, defined by the βα-loops (loops with a β-strand
on the amino end and an α-helix on the carboxy-terminus end),
which are therefore longer than the purely structural αβ-loops31.
That considered, EnvSia156 βα-loops are still remarkably
elongated. A particularly extensive loop is formed by residues
50–85, connecting β-strand 2 to α-helix 2, which is itself an
unusually large helix (residues 86–119) and one of the most
distinctive features of EnvSia156 structure. The C-terminal β-
sandwich domain is formed by eight antiparallel β-strands
organized into two β-sheets, with one sheet formed by strands
1, 3, 6, and 8 and the other by strands 2, 4, and 7, while strand 5 is
shared between the two faces. The larger face of the β-sandwich
folds on itself as the loop connecting β-strands 5 and 6 bends
towards the catalytic domain and interacts with the long 7th βα-
loop of the barrel, contributing for structural stabilization. The
first β-strand of the C-terminal domain is interrupted by a long
loop (residues 382–399) that likely plays a role both in overall
structural stabilization and dimer assembly. With B-factors values
ranging from 16 to 20 it is one of the most rigid features in the
N
or
m
a
liz
e
d 
flu
or
es
ce
nc
e
a b
c d
0.2
0.0
–0.2
3 4 5
pH
6 7 8 0
1.0
pH 5.5
Tm = 72.22 ± 0.15 °C
pH 7.5
Tm = 73.25 ± 0.13 °C
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0
30252015
[DANA] (µM)
1050
0
5
10
V 0
/V
i
65 66 67 68 69 70 71 72 73 74 75 76 77 78
0.04
pKa 6.8
kcat/KM
Stability
0.02
Pr
ot
ei
n 
st
ab
ilit
y 
(%
)
R
at
e 
of
 c
at
al
ys
is 
(µM
.s
–
1 )
k c
a
t/K
M
 
(µM
–
1 s
–
1 )
[4MU-α-Neu5Ac] (µM)
Temperature/°C
120
100
80
60
40
20
0
0.00
50 100 150
0.4
1.0
1.2
1.4
1.6
0.8
0.6
Fig. 1 EnvSia156 activity and stability. a pH dependence of EnvSia156 using 4MU-α-Neu5Ac as substrate to monitor hydrolysis. Red squares show relative
enzyme activity after incubation at different pH. Enzyme activity was assayed at pH 5.5 after preincubating EnvSia156 for 30min at the several pH values.
The rate obtained is shown as a percentage of the rate obtained at pH 7. EnvSia156 is unstable below pH 4 over the time period tested. Blue circles show
the kcat/KM measured at each pH by the substrate depletion method. The profile shows an optimal pH for hydrolysis of 5 with a pKa of 6.8. Experiments
were performed in triplicate. b Michaelis–Menten plot of 4MU-α-Neu5Ac hydrolysis by EnvSia156. Rate of catalysis was determined in triplicate for each
4MU-α-Neu5Ac concentration. c Plot of EnvSia156 V0/Vi against inhibitor concentration [DANA]. Reaction rate was determined by measuring the release
of 4-methylumbelliferone (4MU) in the absence (V0) and presence (Vi) of inhibitor. The 1/Ki value was derived from the slope of the best fit line.
Experiments were performed in triplicate. d DSF curve of EnvSia156 (12.5, 25, 50, and 100 nM) at pH 5.5 and 7.5. Fluorescence measurements were
performed in triplicate. Source data are provided as a Source Data file
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structure, which is unusual for a large loop. This loop makes
several important hydrophobic interactions with both its dimeric
counterpart and the catalytic domain, contributing to the
formation of a continuous cleft connecting the active sites of
the two units in the dimer (Fig. 2c). According to PDBsum32, 20%
of the residues establishing non-bonded contacts between the two
units are located in this loop, highlighting its role in the
dimerization process. An assembly analysis with PISA calculated
an interaction surface area between the two monomers of 1725 Å2
with a predicted solvation energy gain (ΔG) of –13.2 kcal/mol,
suggesting that the observed homodimer formed by the two
copies present in the asymmetric unit is the natural biological
assembly of EnvSia156.
The structure of EnvSia156 is clearly different from all the
known families of both exo-sialidases and endo-sialidases which,
despite some differences regarding accessory domains, substrate-
binding clefts or catalytic residues; all possess a six-bladed β-
propeller topography33–37. A structural similarity search on DALI
server38 using the catalytic domain of EnvSia156 (residues 6–375)
returns Cwp19 “functional” region as the closest structural
homolog (PDB code 5OQ2, z score of 27.2 and rmsd of 3.4 Å over
299 aligned residues39) with 14% identity between aligned
regions. Cwp19, produced by Clostridium difficile during
stationary phase to induce autolysis, has been recently described
as a lytic transglycosylase with activity on peptidoglycan40, but
beyond the superficial fold resemblance there is no conservation
of active center residues and indeed the ligand complexes of
GH156 (vide infra) clash with Cwp19 main chain following
overlap.
The C-terminal β-sandwich domain (residues 376–502) shows
distant homology to a domain from a Bacteroides uniformis
uncharacterized family 86 glycoside hydrolase, possessing agarase
activity (PDB code 5TA5, z score of 11.6 and rmsd of 2.1 over 101
aligned residues). It is also distantly related to a CBM4 domain
appended to a porphyranase produced by Bacteroides plebeius,
similarly classified as a GH86 (PDB code 4AW7, z score of 9.7
and rmsd of 2.0 Å over 102 aligned residues). Both are bacteria
found in the human gut microbiome41,42 thought to have
acquired the GH86 genes by horizontal gene transfer with sea
dwelling organisms. Spatially equivalent surface aromatics
(Supplementary Fig. 2) may imply a CBM-like role for the β-
sandwich domain of EnvSia156, but that remains to be
established.
Complexes and enzyme variants define the active-center and
mechanism. Having ascertained that EnvSia156 indeed displays
an unusual sialidase fold, we next sought to define the active
center of this family. A sequence comparison with the closest
primary structure homologs found in GenBank using the
BLASTP tool (Supplementary Fig. 3), shows that areas with the
highest degree of conservation are mostly found within the β-
strands of the (β/α)8-barrel or just after it, on the “N-terminal”
face of the (β/α)8-barrel.
By coloring the structure according to homology, using the
same color scheme as in the alignment, it is possible to identify a
highly conserved pocket on the “N-terminal” face of the (β/α)8-
barrel that sits at both ends of the continuous groove formed by
a b
c d
e
Fig. 2 The 3-D structure of EnvSia156. a, b Van der Waals’ surface of a EnvSia156 homodimer with one unit colored in light blue and the other in light green.
c “Top-down” view of the dimer with depth shading highlighting the continuous groove connecting the two binding sites. d, e Ribbon representation of the
structure of EnvSia156 with rainbow coloring (N-terminus in blue, C-terminus in red) showing the (β/α)8-barrel fold of the catalytic module and the eight
stranded β-sandwich C-terminal module. A purple colored Neu5Ac molecule in stick representation can be seen bound in the active center of each unit
present in panels b–e
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the dimer (Fig. 3a, b). Considering its position and conservation,
this site is a likely candidate to represent the EnvSia156 catalytic
center. Classic retaining exo-sialidase enzymes have an active
center characterized by a triad of arginines that stabilize the
carboxylate of sialic acid, three catalytic residues—a glutamic
acid, a tyrosine, and an aspartic acid—and an hydrophobic pocket
that accommodates the C5 moiety43. The identified conserved
pocket indeed shows the presence of three 100% conserved
arginines (Arg129, Arg 202, and Arg246), hinting at a sialoside-
binding region, although one of them, Arg246, seems to be too
buried to be able to interact with the carboxylate moiety of sialic
acid. EnvSia156 also displays several highly conserved hydro-
phobic residues forming a pocket that could potentially
accommodate the aglycone moiety of the sialoside substrates.
To better define, the active center residues, 3-D structures were
determined with the product Neu5Ac and with the inhibitor
DANA (Ki 3 μM). Electron density was clear for all ligands
permitting definition of the key elements of sialic acid recognition
for this family (Fig. 4).
The structures with Neu5Ac show the β-anomer (equating to a
product complex following catalytic attack on an α-sialoside with
inversion) of the ligand interacting with EnvSia156 at the
predicted catalytic center based on sequence homology, through
13 hydrogen bonds (with 8 more mediated by water molecules)
and several hydrophobic interactions (Fig. 4a). The –1 subsite,
which accommodates the sialic acid monosaccharide, shows
several differences from what is commonly observed in other
sialidases. It is possible to identify the characteristic triad of
residues coordinating the carboxylate group, although it consists
of two arginine side-chains (Arg129 and Arg202) and one
asparagine (Asn346), instead of the three arginines displayed in
conventional sialidases. Invariant Asp14 lies adjacent to the
(anomeric) C2 carbon and makes a hydrogen bond with the
hydroxyl group. Thus, Asp14 is the most likely candidate to act as
a general catalytic base residue (discussed further below).
Another major difference between EnvSia156 and other
sialidases is the absence of a hydrophobic pocket that accom-
modates the C5 moiety of sialic acids. Rather, the more open
structure of the −1 sub-site orientates the sialic acid in such way
that the functional group at the C5 position is pointing away from
the enzyme. The structure of EnvSia156 with Neu5Ac shows a
single discrete non-bonded contact between Gln351 and the
acetamide methyl group and one water-mediated hydrogen bond
between N5 and Asp14/Ser16. This suggests that EnvSia156 can
tolerate different C5 moieties and explains why, while showing
some preference for Neu5Ac, it can also hydrolyze terminal
Neu5Gc26. To test this supposition, the structure of EnvSia156 in
complex with KDN was obtained, showing that this sialic acid
with a simple hydroxyl group at the C5 position can also be
accommodated (Fig. 4d). All complex structures show the protein
forming hydrogen bonds with all three hydroxyl groups in the
glycerol chain, although the residues involved are not as
conserved as those mentioned above. Tyr20 and Tyr135 bind
with O7 via a water molecule, Ser16 and Asn15 coordinate O8,
and O9 contacts Asp132 and His134 via a water molecule, while
binding directly to Asn15 and Cys53. This is not a common
feature in sialidases and suggests that the glycerol group is a key
feature for substrate recognition. This could also explain why the
activity of EnvSia156 is not inhibited by Siastatin B. Curiously,
both the open structure around the C5 moiety and tight glycerol
chain coordination have been previously reported on a viral
hemagglutinin-neuraminidase (HN)33. In classic sialidases, it is
believed that the hydrophobic pocket accommodating the C5
functional group fixates one end of the sialic acid and allows the
ring distortion that exposes the anomeric carbon. It could be that,
in the case of EnvSia156 and the paramyxovirus HN, this hinge-
like mechanism relies on the immobilization of the glycerol chain
rather than the C5 moiety. The C4 hydroxyl group being
coordinated by Thr352 and Trp279 (via a water-mediated bond).
EnvSia156 acts, in solution at least (see below) on a variety of α2-
3, and α2-6 linked sialic acid glycosides including complex N-
glycans and O-glycan-linked sialic acids. The diversity of
structures accepted as leaving groups suggests a more open and
less hydrogen-bonded environment and indeed we observe a
hydrophobic platform, adjacent to the −1 sub-site. Four highly
conserved aromatic residues, namely Trp164, Phe203, Phe278,
and Trp279, forming a hydrophobic pocket that could possibly
accommodate the aglycone moiety in the+1 binding site (Figs. 3b
and 5).
In the classic retaining mechanism of exosialidases, the
carboxylate group of a glutamate forms a hydrogen bond with
the hydroxyl group of the catalytic tyrosine, increasing its
nucleophilic character, which in turn attacks the anomeric carbon
to form a covalent glycosyl-enzyme intermediate. An aspartate
Asp14
Arg129
His134
Asn46
Trp279
Phe278
Trp164
+1
–1
Phe203
ba
Fig. 3 EnvSia156 homology and binding subsites. a Birdseye view of an EnvSia156 dimer with the van der Waals’ surface colored according to sequence
conservation, calculated by aligning sequences (ClustalOmega) with the closest primary structure homologs found in GenBank using the BLASTP tool. The
color pattern matches the alignment used to render the structure (Supplementary Fig. 3), with darker shades of green corresponding to full conservation
and white to no conservation. b Detailed view of the catalytic site of EnvSia156 with putative substrate coordinating residues in a stick representation,
colored according to sequence conservation. The −1 and putative +1 binding sub-sites are highlighted with dashed circles
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functions as the acid/base residue donating the proton on this
initial step and then facilitating the nucleophilic attack of the
glycosyl-enzyme intermediate44. Contrastingly, but as expected
for an inverting enzyme, none of the signature retaining sialidase
residues are identifiable in the EnvSia156 active site.
EnvSia156 is an inverting enzyme26 which demands two
catalytic residues: a Brønsted acid to protonate the leaving-group
and a Brønsted general base to activate the nucleophilic water
molecule for nucleophilic attack45–48. Asp14 is ideally placed to
assume the role of general base, through its position on the “beta”
face and its direct interaction with the product OH in the Neu5Ac
complex. Furthermore, in the DANA complex, Asp14 coordi-
nates a single water molecule below the anomeric C2 carbon, a
position that mimics what would be seen in a substrate complex.
On the “alpha” face side of the sugar, His134 could potentially act
as the Brønsted acid catalyst that donates the hydrogen to the
leaving group (Fig. 5).
To test the hypothesis that Asp14 and His134 are key catalytic
residues, Asp14 and H134 variants were created. Using the
activated substrate analog 4MU-α-Neu5Ac, all Asp14 mutants
were inactive, consistent with the role of Asp14 as general base. In
contrast, His134 variants suffered a significant drop (~30%) in
activity (Supplementary Fig. 4a), consistent with the reduced need
for protonic assistance to liberate the good leaving group present
on the activated sugar analog substrate. Kinetics using the H134A
variant at pH 5, yielded a kcat of 24.6 ± 0.02 s−1 and KM= 305.52
± 37.8 µM. If H134 functioned as a general acid, we would predict
that it would be less active on less-activated substrates having
higher pKa leaving groups. This was confirmed by incubating a
procainamide-labeled α-2,3-sialyl-lactose substrate at pH 5.5, for
1 h at 37 °C and by detecting both product and substrate by
UPLC. Using these reaction conditions, an equivalent amount of
WT enzyme was able to hydrolyze 77.5 ± 1.8% of the substrate,
whereas no activity was detected for the H134A-mutant enzyme
(Supplementary Fig. 4b). This observation strongly supports the
notion that H134 acts as a general acid during catalysis of natural
substrates. An analogous Asp-His catalytic dyad has been
similarly proposed for members of the GH117 family49,50. They
consist of agarolytic enzymes that act through a single-
displacement inverting mechanism, similar to the one here
proposed for EnvSia156, although in this case the enzymes
display a different beta-propeller fold49,50.
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Fig. 4 Crystal structures of EnvSia156–ligand complexes. The four panels show a detailed view of the crystallized EnvSia156–ligand complexes within the
active center. The enzyme residues making hydrogen-bond contacts (black dashed lines) with the ligands are displayed in stick representation. The ligands
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Despite substantial efforts, we were unable to obtain a
Michaelis complex of EnvSia156 using the His134, Asp14 (or
double) variants. So, in the absence of a true Michaelis complex
for EnvSia156, we overlaid the EnvSia156Neu5Ac structure with
the Michaelis complex of the T. cruzi trans-sialidase with α-2,3-
sialyl-lactose (PDB 1S0I). The Michaelis complex overlay shows
how the carboxylate coordinating triad and a binding pocket that
accommodates the aglycon moiety may contribute to distort the
sialic acid ring exposing the anomeric carbon to nucleophilic
attack35. When overlaying this structure with that of EnvSia156-
Neu5Ac it is possible to speculate that a similar process occurs,
with the carboxylate held in a pseudo-equatorial orientation by
Arg129, Arg202, and Asn346, and the aglycone fitting into the
pocket formed by Trp164, Phe203, Phe278, and Trp279, forcing
the glycosidic bond into a pseudo-axial orientation. This would
likely allow a water molecule to position itself behind the
glycosidic bond. In fact, the structure of EnvSia156 in complex
with the inhibitor DANA (EnvSia156DANA), which simulates
the planar transition state due to its sp2 hybridized C2, shows a
water molecule occupying the same relative position to the
anomeric carbon as the hydroxyl nucleophile of the catalytic
tyrosine in the T. cruzi trans-sialidase, while Asp14 replaces its
glutamate-activating partner (Supplementary Fig. 5). A prior
study by Newstead et al. showed that a retaining sialidase could
be converted into an inverting sialidase by mutation of the
catalytic tyrosine and having a water molecule act as the
nucleophile51. Thus, we speculate that the inverting catalytic
mechanism of EnvSia156 likely involves Asp14-activation of an
analogous nucleophilic water molecule that attacks the anomeric
carbon, with His134 donating a proton to the leaving group
(Fig. 5).
Can GH156 be used for glycocalyx engineering?. Consider-
ing that GH156 defines a sialidase different to all known neur-
aminidases and was active in solution on diverse sialic acids, we
were keen to see if it could be used for engineering of cell-surface
glycosides. When activated, certain Siglec receptors present on
immune cells lead to the suppression of cell-mediated immunity.
Sialic acid glycans present on the glycocalyx of mammalian cells
can activate these receptors and help the immune system to
identify them as self. Certain cancer types have evolved towards
exploiting this system by coating themselves with a large number
of sialylated glycans, which allows them to evade the host
immune system, both cellular and antibody dependent. Indeed,
hypersialylation in cancer is associated with poor prognosis and
decreased immunogenicity52–54. Previous studies have shown
that by conjugating sialidases with antibodies it is possible to
direct their activity towards the specific desialylation of tumor
cells, exposing them to numerous immune pathways16. At first
sight, EnvSia156 seems to be particularly suited for this purpose
as it is capable of binding different sialic acids and has shown to
be active in a variety of sialosides26. Given the potential biome-
dical applications of sialidases, and high specific activity and the
diversity of ligands (α2-3, and 2-6-linked sialic acid glycosides
including complex N-glycans and O-glycan-linked sialic acids26)
Asn15
Asn346
Ser16 H2N H2N
HN
NH
NH2
NH2
H2N
O– H
N
O
O
O
–
+
+
O
O
O
O
C
OH
HO
HO
HO
NH
OH
OH
OH
Asp14
Arg129
Arg202
Thr352
O
O
O
O
COO–
COO– COO–
R R
OH OH ROH OH
NH NH NH
HO
HO
HO
HO HO
HO
HO
HO
HO
H
N
NHis134
Asp14 Asp14
His134
H
N
N
O O
O
O O
O
O
O
H
H
O
H
HO
OH
‡
3.0Å
2.9Å
2.6Å
2.9Å
3.1Å 3.5Å
3.1Å
2.8Å
Asp14
His134
Arg129
Asn346
Arg202
Phe203
Phe278
Trp279
Trp164
a
b c
Fig. 5 EnvSia156 proposed catalytic mechanism. a Proposed inverting mechanism for EnvSia156 with Asp14 acting as the general catalytic base and His134
as the acid catalyst. b Structure of the EnvSia156–Neu5Ac complex highlighting the two putative catalytic residues (Asp14 and His134), the carboxylate-
coordinating triad (Arg129, Arg202, Asn346) and the hydrophobic pocket that possibly constitutes the +1 binding site (Trp164, Phe203, Trp279, Phe278).
c Schematic representation of the Neu5Ac bound to EnvSia156 −1 binding sub-site, showing all the hydrogen bond interactions between both molecules
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12684-7 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:4816 | https://doi.org/10.1038/s41467-019-12684-7 | www.nature.com/naturecommunications 7
in solution, we wanted to test the ability of EnvSia156 sialidase to
remove sialic acids from living cells. The K562 cell line derived
from chronic myelogenous leukemia was used as a model cell line
and treated with EnvSia156 (4.25 μM) to detect sialic acid loss
compared to PBS-treated cells. As a positive control for desialy-
lation, we also treated cells with 0.2 μM of Vibrio cholerae siali-
dase, which has been previously shown to cleave sialic acids from
cell surfaces. Cell-surface sialic acids were analyzed by flow
cytometry detecting lectin binding with Sambucus nigra lectin
(SNA, which binds primarily to α-2,6 sialic acids) and Maackia
amurensis lectin II (MAL II, which binds preferentially to certain
α-2,3-linked sialic acids). Interestingly, at these concentrations
EnvSia156 does not appear to remove MAL II ligands, and only
slightly diminishes SNA binding to the cell surface (Supplemen-
tary Figs. 6 and 7).
Given the catalytic prowess of EnvSia156 towards aryl
sialosides, we were surprised not to see better action on a cellular
model. We have also tested the binding of an inactive (catalytic
base D14A) mutant variant of EnvSia156 using a printed glycan
array consisting of 585 glycans (Supplementary Table 2). Binding
to all glycans was very low with both 5 and 50 μg/mL of protein.
By increasing the concentration to 200 μg/mL, significant
binding, albeit still relatively weak, was detected for the sialoside
Neu5Aca-Sp11 (Supplementary Fig. 8). The signal detected for
the remaining glycans are likely the result of unspecific
interactions, as Neu5Aca-Sp11 is the only consistent binder
across all protein concentrations. Considering the catalytic
activity reported here and by Chuzel et al.26 on labeled sialyl-
lactose and sialyl-lactosamine, we were surprised that no binding
was detected for any of the terminal Neu5Ac-α-(2,6)Gal and
Neu5Ac-α-(2,3)Gal glycans. The general weak binding in the
glycan array appears to corroborate the weak performance on the
K562 cell line, suggesting that some factor, beyond simple
catalytic efficiency, is necessary for efficient glycocalyx engineer-
ing. Perhaps the presence of a true lectin/CBM domain is
essential to target the enzyme to cell-surface glycans (and the
immobilized glycans on the array slide), as it is in the case of the
Vibrio sialidase, for example.
By virtue of its terminal position in protein-linked and lipid-
linked glycans, sialic acid intimately participates in cellular
recognition in both health and disease. Sialidases play key roles in
health, but also in the environmental degradation of sialosides (of
their diverse types). Considering the potential for medical,
dietary, and biotechnological applications of sialidases, there is
a continuing interest in defining new sialidase templates for
application. As part of a screening effort to examine sialidases
from extreme environmental niche, where the role of sialic acids
is poorly understood, EnvSia156 (the defining member of the
GH156) was isolated from a freshwater hot spring26. Here we
show that GH156 sialidases define a distinct paradigm for
sialidase action with His and Asp acting as Brønsted acid and
base, respectively, in an inverting mechanism that is unique
amongst all exo-sialidases described to date. We also show that
this sialidase presents broad ligand specificity and high catalytic
efficiency, meaning it can serve as a template for a variety of
applications where high specific activity is required.
Methods
Gene expression and protein purification. The EnvSia156 gene was PCR-
amplified from a fosmid clone with the addition of a C-terminal hexahistidine tag.
The DNA fragment was inserted into the Ptac promoter expression vector
pJS119K55. Primers were designed using the NEBuilder assembly tool (Supple-
mentary Table 3). PCR products were assembled with the NEBuilder HiFi DNA
Assembly Cloning Kit (New England Biolabs, Ipswich, MA) following the manu-
facturer instructions. The expression construct was verified by Sanger sequencing.
EnvSia156 was expressed in E. coli NEB Express (New England Biolabs, Ipswich,
MA). Expression was performed by addition of IPTG to 0.4 mM and incubation
overnight at 18 °C. Cells from a 1 L culture were harvested by centrifugation at
15,000 × g for 10 min at 4 °C and resuspended in 30 mL of 20 mM sodium phos-
phate, pH 7.4, 500 mM NaCl, and 20 mM imidazole buffer prior to lysis with a TS
Benchtop Series cell disruptor (Constant Systems Limited, Daventry, UK) at 32
kPsi. EnvSia156 was purified on a 5 mL His-TrapTM FF column (GE Healthcare,
Little Chalfont, UK). The bound EnvSia156 was eluted in a 20-column volume
gradient of 20 mM sodium phosphate, pH 7.4 containing 500 mM NaCl and 0–500
mM imidazole. Fractions containing pure protein were pooled and dialyzed against
20 mM sodium phosphate, pH 7.4, containing 500 mM NaCl and 1 mM EDTA.
Expression of seleno-methionine EnvSia156 derivative was performed in E. coli
auxotrophic T7 Express Crystal strain background (New England Biolabs, Ipswich,
MA) using the growth conditions described by Ramakrishnan et al.56 SeMet labeled
cells were harvested by centrifugation at 4500 × g for 25 min at 4 °C. Cell paste from
the 12 L culture was resuspended in 240 mL of 20 mM sodium phosphate, pH 7.4,
500 mM NaCl, 20 mM imidazole buffer and lysed using a TS Benchtop Series cell
disruptor (Constant Systems Limited, Daventry, UK) at 32 kPsi. Purification of the
SeMet-labeled sialidase-6His was performed in two steps. First, sialidase-6His was
bound to a 5 mL His-Trap™ FF column (GE Healthcare, Little Chalfont, UK) and
eluted with a 100 mL 0 to 500 mM imidazole gradient (in 20 mM sodium phos-
phate, pH 7.4, 500 mM NaCl). Fractions (3 mL) containing partially pure protein
were pooled and the resulting solution (63 mL) was concentrated to 2 mL using
Vivaspin 20, 30,000 molecular weight cut off tubes (Sartorius, Göttingen, Ger-
many). Second, gel filtration chromatography was performed using a HiPrep 16/60
Sephacryl S-200 high-resolution column (GE Healthcare, Chicago, IL) and 50 mM
Tris, pH 8.5, 200 mM NaCl buffer. The sample was prepared by diluting 1 mL of
concentrated sialidase-6His with 1 mL of the column buffer and injecting it onto
the column with a 2 mL sample loop. To help the identification of the catalytic
residues D14A and H134A, mutants were generated both on the original gene
(PCR-amplified from the fosmid clone) or by performing site-directed mutagenesis
PCR on a pET29a vector containing the synthesized (Genscript) wild type
EnvSia156 gene (Supplementary Table 4), using the primers shown in Supple-
mentary Table 3. No differences exist between the amplified and synthesized
clones. The synthesized gene and mutant derivatives were generated for ease of
access purposes.
Crystallization of EnvSia156. EnvSia156 at 14.6 mg/mL was tested against a range
of commercial crystallization screens with the addition of 5 mM TCEP to every
condition. The first crystals found consisted in stacks of plates and were used to
create a seed stock. Optimization screens were set with and without seeds. Well
diffracting single crystals were obtained by the sitting drop diffusion method at 293
K with 0.8 M sodium formate, 15% PEG 4000, 0.1 M sodium acetate, pH 6.0 and
with 0.2 M MgCl2 15% PEG 4000, 0.1 M sodium citrate, pH 5.6 using a protein per
well ratio of 1:1. Seleno-methionine EnvSia156 at 21 mg/mL was crystallized using
a similar protocol. The best diffracting crystals were obtained in 0.2 M lithium
sulfate, 15% PEG 4000, 0.1 M sodium acetate, pH 6.0 using a protein per well
solution ratio of 1:1. Crystals were cryoprotected in well solution with 25% glycerol
and flash cooled in liquid N2 for data collection. Protein concentration was
determined in an Epoch microplate spectrophotometer (Biotech), using a calcu-
lated extinction coefficient of 124,705M−1 cm−1.
Substrate and inhibitor complexes. EnvSia156 complexes were generated by co-
crystallization with 20 mM Neu5Ac, Neu5Gc, DANA, or KDN. Initial screens and
optimizations were performed using the same protocol described for the apo
crystals. Ligands were introduced by addition of 0.2 µL of 100 mM stock solution in
water to a 0.8 µL drop with a protein/well solution ratio of 1/1. Well-diffracting
single crystals were obtained with 0.2 M potassium bromide, 15% PEG 4000, 0.1 M
sodium acetate, pH 6.0 (DANA), 0.15 M potassium thiocyanite, 20% PEG 1500,
0.1 M sodium acetate, pH 6.0 (KDN), 0.8 M sodium formate; 12% PEG 4000; 0.1 M
sodium acetate, pH 6.0 (Neu5Ac and Neu5Gc).
3D structure solution. The EnvSia156 SeMet derivative crystal structure was
solved by multiple anomalous dispersion (MAD). Data were collected at beamline
I04 of Diamond Light Source at the selenium peak, inflection, and high-energy
remote wavelengths (0.97946, 0.97965, and 0.97873 Å), processed with DIALS57,
reduced with Aimless58 and phased with the Crank2 pipeline59. The initial model
was subsequently subjected to alternating rounds of manual building and refine-
ment with Coot60 and REFMAC561. The SeMet model was then used to solve the
native apo and ligand crystal structures by molecular replacement. Data for the
apo, NeuGc, and Neu5Ac complex crystals were collected at beamline I04 of the
Diamond Light Source, while data for the remaining crystals were collected at
beamline IO4–1 of the same synchrotron. All datasets were processed with DIALS,
reduced with Aimless and phased with PhaserMR62. The obtain models were
refined as described above. Ligand coordinates were built using JLigand63. wwPDB
Validation Service64 was used to validate the structures before deposition in the
PDB. 3D structure figures were generated using UCSF Chimera65.
Enzyme activity and inhibition assays. Kinetic studies of EnvSia156 were per-
formed at room temperature in flat-bottom 96-well opaque black plates (Thermo
Scientific, Waltham, MA) by monitoring 4MU fluorescence at λex= 365 nm and
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λem= 445 nm in a CLARIOstar microplate reader (BMG Biosciences). A standard
curve was determined for each individual assay in order to convert measured RFU
to 4MU concentration. All assays were performed in triplicate. The optimal pH for
enzyme activity was determined by incubating 140 nM EnvSia156 with 2 mM of
4MU-α-Neu5Ac for 5 min at room temperature in a pH range of 3–8 (200 mM
citrate/phosphate buffer, 0.1% BSA) and stopping the reaction by adding 1M
sodium carbonate buffer at pH 10.4.
Kinetic assays were performed in a total volume of 100 µL buffer (200 mM
citrate/phosphate pH 5, 0.1% BSA) with 10 nM EnvSia156. The reaction was
initiated by the addition of 50 µL of 4MU-α-Neu5Ac to the enzyme for a final
substrate concentration range of 1.17–100 µM.
All data were processed using Origin (OriginLab). Rates were calculated by
linear fit of 4MU concentrations measured between 0 and 48 s and kinetic
parameters were determined using the Michaelis–Menten equation as follows:
v ¼
Vmax S½ 
KM þ S½ 
ð1Þ
Inhibition assays were carried out in a total volume of 100 µL buffer (200 mM
citrate/phosphate pH 5, 0.1% BSA) with 10 nM EnvSia156. The reaction was
initiated by the addition of 50 µL of 4MU-α-Neu5Ac to 50 µL of a solution
containing inhibitor and EnvSia156 for a final substrate concentration of 1 µM.
Inhibitor concentrations used ranged from 0.94 to 30 µM. 4MU release was
recorded continuously over a period of 300 s. Rates were determined in both the
presence and absence of inhibitor. The Ki value was determined using the following
equation:
v0
vi
¼
1
Ki
I½  þ 1 ð2Þ
where v0 and vi are the rates of catalysis in the absence and presence of inhibitor,
respectively. Under conditions where [S]≪ KM, the fractional decrease in rate thus
yields the Ki for a competitive inhibitor. A plot of v0/vi against inhibitor
concentration yields a gradient of 1/Ki, with an intercept of 166.
Measurements of Kcat/KM were carried out by the substrate depletion method27
in a pH range of 3–8. Data were plotted as a function of pH and fitted with the
following four-parameter logistic regression as follows:
Kcat
KM
¼
Kcat
KM
minþ
Kcat
KM
max Kcat
KM
min
1þ 10ðpKapHÞ ´HillSlope
 !
ð3Þ
UPLC with procainamide labeled glycans. The enzymatic activity of wild type
EnvSia156 and H134A mutant were tested by incubating 0.05, 0.15, 0.3, and 0.6 µg
of enzyme with procainamide labeled 3’sialyllactose substrate in 50 mM sodium
acetate pH 5.5, for 1 h at 37 °C. After incubation, 2.4 μL of sample were mixed with
17.6 µL acetonitrile for a 12:88 ratio. Sixteen microliters were injected into a Waters
Acquity BEH glycan amide column (2.1 × 150 mm, 1.7 μm) on a Waters
ACQUITY UPLC H-Class instrument (Waters Corporation, Milford, MA)
equipped with a quaternary solvent manager and a fluorescence detector. Solvents
used were A: 50 mM ammonium formate buffer pH 4.4 and B: 100% acetonitrile.
The gradient used was 0–1.50 min, 12% solvent A; 1.5–35 min, 47% solvent A;
35–36.5 min, 70% solvent A; 36.5–42 min, 12% solvent A with a flow rate of 0.561
mL/min. Samples were kept at 5 °C prior to injection and separation was per-
formed at 30 °C. The fluorescence detection wavelengths were λex= 308 nm and
λem= 359 nm with a data collection rate of 20 Hz. Data were analyzed with
Empower 3 chromatography workstation software (Waters Corporation).
SEC-MALLS. SEC-MALLS experiments were run in 20 mM HEPES 7.4, 300 mM
NaCl buffer. The injected sample comprised 100 µL of EnvSia156 at 1.8 mg mL−1
in 20 mM HEPES pH 7.4, 100 mM NaCl, 1 mM DTT. Experiments were conducted
on a system comprising a Superdex 200 10/30 GL (GE Healthcare) size exclusion
chromatography column, a Wyatt HELEOS-II multi-angle light scattering detector
and a Wyatt rEX refractive index detector linked to a Shimadzu HPLC system
(SPD-20A UV detector, LC20-AD isocratic pump system, DGU-20A3 degasser,
and SIL-20A autosampler). Work was conducted at room temperature (20 ± 2 °C).
All solvents and buffers were 0.2 µm filtered before use and a further 0.1 µm filter
was present in the flow path. Shimadzu LC Solutions software was used to control
the HPLC and Astra V software for the HELEOS-II and rEX detectors. All data
were analyzed using the Astra V software. Molecular masses were estimated using
the Zimm fit method with degree 1. A value of 0.16 mL g−1 was used for protein
refractive index increment (dn/dc), after calibration with a 2.5 mg mL−1 sample
of BSA.
Differential scanning fluorimetry. DSF experiments were performed in eight
0.2 mL polypropylene PCR tube strips (Agilent) with a final volume of 25 µL per
tube. The sample mixture contained EnvSia156 (at 12.5, 25, 50, or 100 µM) and
Sypro Orange dye (200 ng µL−1) in McIlvaine buffer at pH 5.5 and 7.5. Melting
data were collected using the Agilent Stratagene Mx3005P rtPCR machine ramping
from 25 to 95 °C at 30 s per degree. Data were analyzed using the JTSA server
(http://paulsbond.co.uk/jtsa). Data points to the right of the highest fluorescence
and to the left of the lowest fluorescence were discarded. The remaining points
were fitted with a five parameter sigmoid equation (Sigmoid-5) model using the
Levenberg–Marquardt algorithm.
Cell culture. K562 cells (ATCC) were grown in RPMI 1640 medium (Corning,
MT10040CV)+ 10% heat-inactivated fetal bovine serum (heat inactivated)
(Corning, 35016CV)+ 1% penicillin/streptomycin (Fisher Scientific, sv30010), and
tested negative for mycoplasma contamination by the MycoAlert PLUS myco-
plasma test kit (Lonza, LT07-710).
Vibrio cholerae NanH sialidase expression. The V. cholerae sialidase expressing
plasmid pCVD364 expressed in E. coli C600 cells was a gift from Eric R. Vimr at
the University of Illinois, Urbana-Champaign67. For expression, 6 mL of starter
culture was grown for 8–12 h and used to inoculate 3 L of 2xYT media supple-
mented with 100 μg mL−1 carbenicillin at 37 °C for 12 h. Cells were pelleted by
centrifugation at 4000 × g for 10 min. The pellet was resuspended in osmotic shock
buffer (20% (w/vol) sucrose, 1 mM EDTA, 30 mM Tris–HCl, pH 8.0) and shaken
gently for 10 min at room temperature. Cells were collected by centrifugation
(9000 × g for 10 min), and resuspended in ice-cold water. After a 10 min incubation
at 4 °C, the supernatant was obtained by centrifugation at 9000 × g for 10 min. The
sample was concentrated using an Amicon ultrafiltration filter (MWCO= 50,000
Da), reconstituted in 20 mMM Tris–HCl buffer pH 7.6, run through a 0.2 μm
syringe filter, and loaded onto a HitrapQ-HP anion-exchange column (17-1154-01;
GE Healthcare Life Sciences) on an ÄKTA pure protein purification system at a
flow rate of 3 mL/min. Buffers used were A: 20 mM Tris–HCl pH 7.6 and B: 20 mM
Tris–HCl pH 7.6+ 1M NaCl. The gradient used was 0–10 CV, hold at 0% B,
10–14 CV, linear gradient to 10% B, 14–26 CV, linear gradient to 30% B, 26–31
CV, step to 100% B. The majority of sialidase eluted around 22% B; these sialidase
fractions were collected and pooled. Endotoxins were removed using a high-
capacity endotoxin removal spin kit (88275; Thermo Fisher Scientific). Con-
centration was determined using the protein absorbance at 280 nm using the
Nanodrop 2000 Spectrophotometer and the calculated molar extinction coefficient
of 131780M−1 cm−1.
Lectin staining. K562 cells were resuspended in normal growth media and 300,000
cells/well were distributed into a V-bottom 96-well plate (Fisher Scientific,
0720096). Sialidases or PBS were added to respective wells to final concentrations
of 4.25 μM (EnvSia156), 0.2 μM (Vibrio cholerae nanH sialidase), or equivalent
volume PBS as a control. Cells were incubated with sialidase for 2 h at 37 °C, 5%
CO2. Cells were then pelleted by centrifugation at 500 × g for 5 min. Supernatant
was removed and replaced with 200 μL of biotinylated lectins at 10 μg mL−1 in cold
PBS+ 0.5% BSA (Sigma A9647-100G), lectins: biotinylated Sambucus nigra lectin
(SNA) (Vector Labs, B-1305), or biotinylatedMaackia amurensis lectin II (MAL II)
(Vector Labs, B-1265). Cells were incubated with lectins for 30 min at 4 °C, fol-
lowed by three washes (centrifugation at 500×g for 5 min, removal of supernatant,
and resuspension in cold PBS+ 0.5% BSA). After the final wash, cells were
resuspended in 2.5 μg mL−1 streptavidin-Alexa Fluor 647 (Thermo Fisher Scien-
tific, S21374) in cold PBS+ 0.5% BSA and incubated at 4 °C for 15 min. Three
more washes were performed and the cells were resuspended in PBS+ 0.5% BSA
containing 100 nM Sytox Green (Thermo Fisher Scientific, S7020) and analyzed on
an LSR II flow cytometer (BD Biosciences). Cells were gated as shown in Sup-
plementary Fig. 6; gating was performed using FlowJo v10.0 software to eliminate
debris (FSC/SSC), analyze only single cells (FSC-A/FSC-H), and then select for live
cells (Sytox green negative). Three independently performed experiments following
this protocol were performed, all had >25,000 cells in the final gated population.
The fold change in geometric mean fluorescence intensity (gMFI) over cells that
were not lectin stained was plotted using GraphPad Prism v6 in Supplementary
Fig. 7.
Glycan array. Glycan array screening was performed by the Protein–Glycan
Interaction Resource of the Consortium for Functional Glycomics, located at the
National Center for Functional Glycomics (NCFG), Beth Israel Deaconess Medical
Center, Harvard Medical School. The binding of an inactive variant (D14A mutant)
of EnvSia156 was tested using the CFG-printed array version 5.4, which consists of
585 glycans in replicates of 6. The experiment was performed as described in https://
ncfg.hms.harvard.edu/protocols/glycan-binding-assay-fusion-or-epitope-tagged-
protein, using 5, 50, and 200 μgmL−1 of EnvSia156 and 5 μg mL−1 of Alexa-Fluor-
488-labeled anti-His antibody for detection of bound sample.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Coordinates and structure factors have been deposited in the Protein Data Bank under
accession codes PDB 6RZD [https://www.rcsb.org/structure/6RZD] (unliganded
structure), PDB 6S00 [https://www.rcsb.org/structure/6S00] (Neu5Ac complex), PDB
6S04 [https://www.rcsb.org/structure/6S04] (Neu5Gc complex), PDB 6S0E [https://www.
rcsb.org/structure/6S0E] (DANA complex) and PDB 6S0F [https://www.rcsb.org/
structure/6S0F] (KDN complex). The source data underlying Fig. 1 and Supplementary
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Figs. 1, 4a, 7b and 8 are provided as a Source Data file. All further data supporting the
findings of this study are available from the corresponding authors, upon reasonable
request.
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